Home » EC Seeks Faster Turnaround on Pricing, Reimbursement Decisions
EC Seeks Faster Turnaround on Pricing, Reimbursement Decisions
March 8, 2012
Drug sponsors may be able to bring novel and generic drugs to market earlier in the EU and be eligible for damages if states don’t meet deadlines for pricing and reimbursement decisions, under proposed legislation adopted by the European Commission March 1.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor